AIT India 2026/27: Juvion Health Sciences
Meet Sébastien Guilmot, one of the ten Switzerland-based participants in the 2026/27 edition of the Academia-Industry Training India program.
Interview with Sébastien Guilmot
“Juvion closes the gap between lifespan and health span, how long we live versus how well we live by addressing the loss of mobility with age. Our research showed that age-related decline in neuron-muscle connectivity can be prevented, the foundation for HS1, our first supplement targeting the neuro-muscular junction.”
What problem does your startup solve, and why is it important to you personally?
Juvion closes the gap between lifespan and health span, how long we live versus how well we live by addressing the loss of mobility with age. Our research showed that age-related decline in neuron-muscle connectivity can be prevented, the foundation for HS1, our first supplement targeting the neuro-muscular junction. It matters to me because staying independent longer means easing the burden for families and society. And I lead the operations, turning that science into a product people can receive.
What inspired you to become a sciencepreneur, and what has been your biggest “aha!” moment so far?
After seeing the potential of our research, the main inspiration was the will to transfer a reliable and critical result from the lab to the people needing it. The biggest “aha!” moment was definitely when we saw a sizeable increase in mobility in our models with our formulation.
What unique perspective does your academic background bring to your startup?
My background is in environmental microbiology, but my most relevant inputs for Juvion come from my previous experience, where I ran aging-related drug screening on model organisms and managed a lab. At Juvion, I lead operations, using Flygym, our screening pipeline, to test compound candidates for neuromuscular health. That hands-on screening and lab-operations experience lets me bridge our research and our product.
What’s one surprising lesson you’ve learned since launching your startup?
The surprising part was discovering how much of “getting research to people” is logistics and paperwork. Coordinating international shipments and navigating regulatory requirements across countries taught me that a good formulation means nothing if it can’t legally and physically arrive where someone needs it. The lab result is just a part of the end goal; the rest is making it real.
If you could host a dinner with three innovators (past or present), who would they be and why?
Seymour Benzer, who pioneered using fruit flies to study behavior and neurobiology, the same logic behind FlyGym. Cynthia Kenyon, whose work on the genetics of aging reframed longevity as something biology could intervene on. Henri Nestlé, who turned a nutritional discovery into a product that reached households worldwide, exactly the leap from lab to shelf that JuvHS1 is making now. I’d ask all three the same question: how do you know when a discovery is ready to leave the lab?